Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
INHIBITEX, INC. (INHX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/16/2012 8-K Quarterly results
01/10/2012 8-K Form 8-K - Current report
11/29/2011 8-K Form 8-K - Current report
11/04/2011 8-K Form 8-K - Current report
08/18/2011 8-K Form 8-K - Current report
08/08/2011 8-K Quarterly results
Docs: "INHIBITEX REPORTS SECOND QUARTER 2011 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS"
06/20/2011 8-K Form 8-K - Current report
05/09/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "Staphylococcus aureus Investigational Vaccine Elicits a Positive Immune Response in Phase 1study"
05/06/2011 8-K Quarterly results
Docs: "INHIBITEX REPORTS FIRST QUARTER 2011 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS"
04/13/2011 8-K Form 8-K - Current report
04/12/2011 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "INHIBITEX ANNOUNCES EXERCISE OF UNDERWRITERS' OVERALLOTMENT OPTION AND CLOSING OF UNDERWRITTEN PUBLIC OFFERING"
04/07/2011 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Equity Underwriting Agreement between the Company and Deutsche Bank Securities Inc., as representative of the underwriters named therein",
"Opinion of Dechert LLP",
"INHIBITEX PRICES $47 MILLION PUBLIC OFFERING ATLANTA, GA - April 7, 2011"
04/06/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "INHIBITEX ANNOUNCES PROPOSED PUBLIC OFFERING ATLANTA, GA - April 6, 2011"
03/31/2011 8-K Form 8-K - Current report
03/11/2011 8-K Form 8-K - Current report
01/10/2011 8-K Form 8-K - Current report
12/13/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "INHIBITEX REPORTS PROMISING TOP-LINE RESULTS FROM PHASE II TRIAL OF FV-100 FOR THE TREATMENT OF SHINGLES"
11/09/2010 8-K Quarterly results
Docs: "INHIBITEX REPORTS THIRD QUARTER FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS"
11/01/2010 8-K Form 8-K - Current report
10/15/2010 8-K Form 8-K - Current report
09/01/2010 8-K Form 8-K - Current report
08/10/2010 8-K Form 8-K - Current report
07/23/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "INHIBITEX REPORTS INDEPENDENT DATA SAFETY MONITORING BOARD RECOMMENDS CONTINUATION OF PHASE II CLINICAL TRIAL OF FV-100"
06/24/2010 8-K Submission of Matters to a Vote of Security Holders
06/16/2010 8-K/A Form 8-K - Current report [amend]
06/15/2010 8-K Other Events
04/12/2010 8-K Form 8-K - Current report
03/23/2010 8-K Form 8-K - Current report
02/22/2010 8-K Form 8-K - Current report
02/05/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "INHIBITEX REGAINS COMPLIANCE WITH NASDAQ LISTING REQUIREMENTS"
01/11/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "INHIBITEX PROVIDES UPDATE ON ITS STAPH VACCINE, FV-100 AND INX-189 DEVELOPMENT PROGRAMS"
12/28/2009 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "INHIBITEX RECEIVES NASDAQ NOTIFICATION"
11/06/2009 8-K Form 8-K - Current report
10/30/2009 8-K Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
Docs: "INHIBITEX COMPLETES $23 MILLION FINANCING"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy